U.S. Markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
118.95+0.16 (+0.13%)
At close: 5:06PM EDT

118.80 -0.15 (-0.13%)
After hours: 7:23PM EDT

Abbott Laboratories

100 Abbott Park Road
Abbott Park
North Chicago, IL 60064-6400
United States
224 667 6100
http://www.abbott.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees109,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Miles D. White M.B.A.Exec. Chairman4.41MN/A1955
Mr. Robert B. FordPres, CEO & Director5.05MN/A1974
Mr. Robert E. Funck Jr.Exec. VP of Fin. & CFO2.43M8.13M1961
Mr. Hubert L. AllenExec. VP, Gen. Counsel & Sec.1.82MN/A1966
Mr. Daniel Gesua Sive SalvadoriExec. VP of Nutritional Products1.69M2.76M1979
Mr. John F. GinascolExec. VP of Core Diagnostics1.68M8.42M1959
Mr. Gregory A. AhlbergSr. VP of Core Laboratory Diagnostics & Commercial OperationsN/AN/A1967
Mr. Scott Michael LeinenweberVP of Investor Relations, Licensing & AcquisitionsN/AN/A1972
James E. YoungVP and Chief Ethics & Compliance OfficerN/AN/AN/A
Ms. Melissa BrotzVP of Public Affairs & Corp. MarketingN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.

Corporate Governance

Abbott Laboratories’s ISS Governance QualityScore as of April 30, 2021 is 7. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.